pillbase.ru

Focus

Wirkstoff: GINKGO, OXOGLURIC ACID, IODINE, PHOSPHORUS, LACTIC ACID, L-, SUCROSE, ADENOSINE CYCLIC PHOSPHATE, SUS SCROFA CEREBRUM, SUS SCROFA HYPOTHALAMUS, SILICON DIOXIDE, EPINEPHRINE, AMBERGRIS, CARBON DISULFIDE, LYCOSA TARANTULA, AETHUSA CYNAPIUM, BARIUM CARBONATE, HELLEBORUS NIGER ROOT, VERATRUM ALBUM ROOT, CANDIDA ALBICANS, HYOSCYAMUS NIGER

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · GINKGO 3 [hp_X]/mL, OXOGLURIC ACID 6 [hp_X]/mL, IODINE 6 [hp_X]/mL, PHOSPHORUS 6 [hp_X]/mL, LACTIC ACID, L- 6 [hp_X]/mL, SUCROSE 6 [hp_X]/mL, ADENOSINE CYCLIC PHOSPHATE 8 [hp_X]/mL, SUS SCROFA CEREBRUM 8 [hp_X]/mL, SUS SCROFA HYPOTHALAMUS 8 [hp_X]/mL, SILICON DIOXIDE 8 [hp_X]/mL, EPINEPHRINE 8 [hp_X]/mL, AMBERGRIS 9 [hp_X]/mL, CARBON DISULFIDE 9 [hp_X]/mL, LYCOSA TARANTULA 10 [hp_X]/mL, AETHUSA CYNAPIUM 12 [hp_X]/mL, BARIUM CARBONATE 12 [hp_X]/mL, HELLEBORUS NIGER ROOT 12 [hp_X]/mL, VERATRUM ALBUM ROOT 12 [hp_X]/mL, CANDIDA ALBICANS 12 [hp_X]/mL, HYOSCYAMUS NIGER 12 [hp_X]/mL

Vereinigte StaatenAktiv

Zulassungsinhaber: Deseret Biologicals, Inc.

Geprüft 2026-10-09 · openFDA NDC

Zusammensetzung
  • GINKGO · 3 [hp_X]/mL
  • OXOGLURIC ACID · 6 [hp_X]/mL
  • IODINE · 6 [hp_X]/mL
  • PHOSPHORUS · 6 [hp_X]/mL
  • LACTIC ACID, L- · 6 [hp_X]/mL
  • SUCROSE · 6 [hp_X]/mL
  • ADENOSINE CYCLIC PHOSPHATE · 8 [hp_X]/mL
  • SUS SCROFA CEREBRUM · 8 [hp_X]/mL
  • SUS SCROFA HYPOTHALAMUS · 8 [hp_X]/mL
  • SILICON DIOXIDE · 8 [hp_X]/mL
  • EPINEPHRINE · 8 [hp_X]/mL
  • AMBERGRIS · 9 [hp_X]/mL
  • CARBON DISULFIDE · 9 [hp_X]/mL
  • LYCOSA TARANTULA · 10 [hp_X]/mL
  • AETHUSA CYNAPIUM · 12 [hp_X]/mL
  • BARIUM CARBONATE · 12 [hp_X]/mL
  • HELLEBORUS NIGER ROOT · 12 [hp_X]/mL
  • VERATRUM ALBUM ROOT · 12 [hp_X]/mL
  • CANDIDA ALBICANS · 12 [hp_X]/mL
  • HYOSCYAMUS NIGER · 12 [hp_X]/mL
Zulassung
Zulassungsnummer
43742-1201
Zulassungsstatus
Aktiv
Abgabe
Rezeptfrei
Art der Anwendung
ORAL
Quellen